Adamis Pharmaceuticals Corporation recalls SYMJEPI (epinephrine injection, USP) 0.3 mg, (0.3 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, M
Recalled April 13, 2022 · FDA recall D-0763-2022 · Adamis Pharmaceuticals
Hazard
Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine. · FDA Class I
Units
25,103 cartons
Sold at
Nationwide in the U.S.A.
Description
Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
Product
SYMJEPI (epinephrine injection, USP) 0.3 mg, (0.3 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-130-02
Manufacturer(s)
Adamis Pharmaceuticals Corporation
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →